Bühring Hj

676 total citations
12 papers, 538 citations indexed

About

Bühring Hj is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Bühring Hj has authored 12 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Hematology and 5 papers in Immunology. Recurrent topics in Bühring Hj's work include Immunotherapy and Immune Responses (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Acute Myeloid Leukemia Research (2 papers). Bühring Hj is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Hematopoietic Stem Cell Transplantation (3 papers) and Acute Myeloid Leukemia Research (2 papers). Bühring Hj collaborates with scholars based in Germany, France and Norway. Bühring Hj's co-authors include A. Ullrich, Chrystel Lavagna, Daniel Birnbaum, Irène Rappold, Christian Chabannon, Charles Hannum, Kurt Schaudt, Olivier Rosnet, Sylvie Marchetto and Christine Arnoulet and has published in prestigious journals such as Blood, BMC Cancer and PubMed.

In The Last Decade

Bühring Hj

12 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bühring Hj Germany 7 281 211 158 138 107 12 538
IB Pragnell United Kingdom 9 282 1.0× 148 0.7× 171 1.1× 156 1.1× 105 1.0× 10 479
McCulloch Ea Canada 16 365 1.3× 268 1.3× 144 0.9× 110 0.8× 115 1.1× 30 632
J. Graham Sharp United States 12 255 0.9× 181 0.9× 113 0.7× 250 1.8× 96 0.9× 26 633
Saul J. Sharkis United States 6 384 1.4× 283 1.3× 183 1.2× 178 1.3× 173 1.6× 6 703
F W Jacobsen Norway 8 208 0.7× 207 1.0× 247 1.6× 113 0.8× 83 0.8× 9 547
R. Nayar Canada 9 323 1.1× 170 0.8× 131 0.8× 178 1.3× 127 1.2× 14 563
MJ Pébusque France 12 534 1.9× 243 1.2× 241 1.5× 127 0.9× 205 1.9× 19 810
Qian‐Lin Hao United States 13 249 0.9× 312 1.5× 316 2.0× 144 1.0× 169 1.6× 17 831
P. M. Lansdorp Canada 12 563 2.0× 222 1.1× 191 1.2× 93 0.7× 180 1.7× 13 827
J. W. G. Janssen Germany 13 271 1.0× 234 1.1× 111 0.7× 68 0.5× 127 1.2× 18 564

Countries citing papers authored by Bühring Hj

Since Specialization
Citations

This map shows the geographic impact of Bühring Hj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bühring Hj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bühring Hj more than expected).

Fields of papers citing papers by Bühring Hj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bühring Hj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bühring Hj. The network helps show where Bühring Hj may publish in the future.

Co-authorship network of co-authors of Bühring Hj

This figure shows the co-authorship network connecting the top 25 collaborators of Bühring Hj. A scholar is included among the top collaborators of Bühring Hj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bühring Hj. Bühring Hj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Jung, Younghun, et al.. (2006). The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer. 6(1). 195–195. 66 indexed citations
2.
Glück, T., R Seelig, Bühring Hj, et al.. (1997). Parameters predicting response to alpha-interferon treatment in chronic hepatitis C.. PubMed. 44(14). 484–91. 4 indexed citations
3.
Brugger, Wolfram, Stefan Scheding, Wichard Vogel, et al.. (1996). Ex vivo manipulations of CD34+ peripheral blood progenitor cells.. PubMed. 18 Suppl 1. S5–7. 2 indexed citations
4.
Rosnet, Olivier, Bühring Hj, Sylvie Marchetto, et al.. (1996). Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.. PubMed. 10(2). 238–48. 196 indexed citations
5.
Batard, Pascal, P Sansilvestri, Clemens Scheinecker, et al.. (1996). The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood. 87(6). 2212–2220. 64 indexed citations
7.
Bruserud, Øystein, et al.. (1995). Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.. PubMed. 9(11). 1910–20. 59 indexed citations
9.
Hj, Bühring, et al.. (1991). The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.. PubMed. 5(10). 854–60. 85 indexed citations
10.
Pawelec, Graham, U. Schwuléra, Heinz‐Josef Lenz, et al.. (1990). Lymphokine release, suppressor cell generation, cell surface markers, and cytotoxic activity in cancer patients receiving natural interleukin-2.. PubMed. 2(1). 44–9. 6 indexed citations
11.
Pawelec, Graham, et al.. (1988). "Tolerization" of human T-helper cell clones by chronic exposure to alloantigen: culture conditions dictate autocrine proliferative status but not acquisition of cytotoxic potential and suppressor-induction capacity.. PubMed. 4(1). 21–34. 4 indexed citations
12.
Maier, Bernhard, Bühring Hj, Markus M. Simon, Klaus Eichmann, & Inga Melchers. (1986). Limiting dilution analysis of proliferating and helper T cells in the in vivo immune response to KLH: derepression of helper T cells at moderately increased frequencies.. PubMed. 2(5). 293–305. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026